Immunomodulation using agonists and antagonists: potential clinical applications.

Area of Science:

• Immunology
• Pharmacology
• Drug Discovery

Background:

• The innate and adaptive immune systems interact via receptor-ligand signaling to combat disease.
• While Toll-like Receptors (TLRs) are well-studied, other receptor families are crucial in various pathologies.
• Research focuses on identifying novel agonists and antagonists for therapeutic development.

Purpose of the Study:

• To review recent advances in drug discovery targeting key immune receptors.
• To examine therapeutic strategies for receptors like G-protein coupled receptors, TRAIL-R, IL-1β receptor, and PPARs.
• To assess the clinical trial status of these immunomodulatory therapeutics.

Main Methods:

• Review of recent literature on drug discovery targeting immune receptors.
• Focus on innovative paradigms for generating specific and effective therapeutics.
• Analysis of receptor-ligand interactions in immune system cross-talk.

Main Results:

• Identification of key receptors (GPCRs, TRAIL-R, IL-1βR, PPARs) involved in immune response modulation.
• Overview of current therapeutic approaches and their clinical trial progression.
• Highlighting the importance of receptor-ligand interactions in immune function.

Conclusions:

• Developing specific agonists/antagonists is challenging due to non-specific activation.
• Innovative ligand design, including allosterism and dual-specific ligands, is essential.
• Rigorous preclinical and clinical studies are vital for therapeutic translation.